Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
119 studies found for:    hepatitis c phase 3 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C
Intervention: Drug: No Treatment
2 Recruiting Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/VEL
3 Recruiting A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment
Condition: Hepatitis C Virus (HCV)
Intervention: Drug: Glecaprevir/Pibrentasvir
4 Recruiting A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Condition: Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Intervention: Drug: Glecaprevir/Pibrentasvir
5 Recruiting A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Condition: Chronic Hepatitis C Virus (HCV)
Intervention: Drug: Glecaprevir/Pibrentasvir
6 Recruiting Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
Conditions: Hepatitis C;   HCV
Interventions: Drug: Glecaprevir/Pibrentasvir (G/P) 300mg/120mg;   Drug: Ribavirin 200Mg Tablet
7 Recruiting Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/VEL
8 Recruiting Swiss HCVree Trial
Conditions: Hepatitis C;   HIV
Interventions: Drug: grazoprevir/elbasvir, ribavirin;   Behavioral: Behavioural Intervention
9 Recruiting Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis
Condition: Hepatitis C Virus Infection
Interventions: Drug: SOF/VEL;   Drug: RBV
10 Not yet recruiting Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection
Conditions: Hepatitis C, Chronic;   Opioid-use Disorder
Intervention: Drug: Sofosbuvir/Velpatasvir
11 Recruiting A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ombitasvir;   Drug: paritaprevir;   Drug: ritonavir;   Drug: dasabuvir;   Drug: ribavirin
12 Not yet recruiting Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.
Condition: Hepatitis C
Interventions: Drug: SOF/VEL for 6 weeks;   Drug: SOF/VEL for 12 weeks
13 Recruiting A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C Virus (HCV)
Intervention: Drug: Glecaprevir/Pibrentasvir
14 Not yet recruiting Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients
Condition: Hepatitis C
Interventions: Drug: Sofosbuvir/Ledipasvir 12W;   Drug: Sofosbuvir/Ledipasvir plus Ribavirin 12W;   Drug: Sofosbuvir/Ledipasvir 24W;   Drug: Sofosbuvir/Ledipasvir plus Ribavirin 24W
15 Not yet recruiting Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients
Conditions: Hepatitis C;   HIV
Interventions: Drug: Grazoprevir 100 mg/d 8 weeks;   Drug: Elbasvir 50 mg/d 8 weeks;   Drug: Grazoprevir 100 mg/d 12 weeks;   Drug: Elbasvir 50 mg/d 12 weeks
16 Not yet recruiting Assessment Status After Direct Acting Antiviral in Hepatitis c Virus Patients
Condition: Chronic Hepatitis c
Interventions: Drug: Sofosbuvir , daclatasvir;   Drug: Placebos
17 Not yet recruiting Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures
Condition: Hepatitis C
Interventions: Drug: 12 weeks without Ribavirin;   Drug: 12 weeks with Ribavirin;   Drug: 24 weeks with Ribavirin
18 Not yet recruiting Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients
Condition: Hepatitis C, Chronic
Intervention: Drug: glecaprevir (300mg)/pibrentasvir (120mg)
19 Recruiting Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C
Conditions: Hepatitis C;   Alcohol Abuse
Interventions: Other: Web-Based Brief Alcohol Intervention;   Other: Usual Care
20 Recruiting Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
Conditions: Hepatitis C;   Cryoglobulinemia
Intervention: Drug: Harvoni

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.